https://www.marketscreener.com/quote/stock/SORIN-SPA-104902/news/Sorin-Completes-Enrollment-in-the-RESPOND-CRT-IDE-Clinical-Trial-Using-Innovative-Heart-Failure-Ma-19310187/?utm_source=telegram&utm_medium=social&utm_campaign=share